Gremlin-1 augments the oestrogen-related receptor α signalling through EGFR activation: implications for the progression of breast cancer.
Sin-Aye ParkNam Ji SungBae-Jung ChoiWonki KimSeung Hyeon KimYoung-Joon SurhPublished in: British journal of cancer (2020)
Our study suggests that the GREM1-ERRα axis can serve as a potential therapeutic target in the management of cancer, especially ER-negative tumour.